Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of plant-derived recombinant growth factors in skin care

A growth factor and skin technology, applied in the application field of plant-derived recombinant growth factors in skin care, can solve problems such as interference with the immune system, instability, and carrying

Inactive Publication Date: 2012-01-04
ORF ELEVATORAEKNI HF
View PDF7 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The same risk of contaminating transmissible and endogenous growth factors exists in growth factors produced by biotechnological means in animal or human cells
Biotechnologically produced growth factors in bacteria that pose a risk of carrying bacterial endotoxins known to be pyrogenic and interfere with the immune system
Furthermore, bacteria are unable to glycosylate proteins, which in several cases is known to render them unstable and more susceptible to degradation by proteases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of plant-derived recombinant growth factors in skin care
  • Use of plant-derived recombinant growth factors in skin care
  • Use of plant-derived recombinant growth factors in skin care

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0068] Example 1: Partially purified transgenic plant extracts containing recombinant growth factors and dehydrin Fetch

[0069] Transgenic plant extracts were prepared by milling harvested transgenic barley seeds containing the recombinant growth factor mouse stem cell factor (mSCF) in a grinder to obtain a fine powder (flour). Extraction buffer (50 mM potassium phosphate, pH 7.0) was added to the milled barley flour at a volume / weight ratio of extraction buffer to milled flour of 5 / 1. The resulting solution was stirred at 4°C for 60 minutes. The solids were separated from the liquid extract by centrifugation at 8300 rpm or above for 15 minutes in a refrigerated centrifuge (Heraeus Primo R) and the supernatant was decanted into a new vial. The growth factor content of the extracts was analyzed by SDS-PAGE and Western blotting using specific antibodies. In this experiment, the content of mSCF was about 0.1% of the protein content of the unpurified extract.

[0070] The ...

Embodiment 2

[0071] Example 2: Extraction of recombinant growth factor mSCF purified from transgenic barley seed extracts purification

[0072] For further isolation of the growth factor in purified form: the IMAC eluate from Example 1 was applied to an ion exchange column Sepharose FF after buffer shift using gel filtration and carried out by increasing the NaCl content of the elution buffer Gradually eluted to separate the protein in the extract. In this way, growth factors can be successfully separated from dehydrin. Bands are blurred due to glycosylation of mSCF. as figure 1 In this way, it was shown that growth factors could be purified to a high purity of >95% (lane 6), resulting in isolated and purified mSCF isolated and purified from transgenic plant extracts.

[0073] figure 1 Transgenic plant extracts and purification and isolation of murine stem cell factor (mSCF) from transgenic plant extracts are shown.

[0074] A) Coomassie blue stained SDS-PAGE gel staining the extr...

Embodiment 3

[0078] Example 3: Glycosylation of recombinant growth factors expressed in plants

[0079]Human gamma-interferon was expressed in barley and the extraction of total protein was carried out under reducing conditions in the presence of 170 mM NaCl, 1% 2-mercaptoethanol, 10 mM Tris-HCl pH 8.0 and 1% polyvinylpyrrolidone (MW 360.000). After the samples had been ground, 5 ml of extraction buffer was added to the extraction bottle. Extracts were clarified by centrifugation at 4000 rpm for 10 minutes at 4°C, followed by 10-fold centrifugal concentration in Ultrafree-4 concentrators using a 5 kDa molecular weight cut-off (UFV4BCC00-Millipore Corp. Bedford, MA, USA). Add 100 μl of the clarified and concentrated extract sample to 100 μl of 2x sample buffer and place the mixture in a boiling water bath for 5 min. After cooling, 10 μl of samples were loaded onto a 12% polyacrylamide gel and separated by SDS-PAGE. The results of the comparative examples were illustrated by Western blot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Cosmetic and therapeutic compositions for skin care, containing a transgenic plant extract containing a growth factor, or a growth factor purified from transgenic plants, or a mixture of growth factors derived from transgenic plants as extracts or in purified form, for use in topical therapeutic and / or cosmetic applications. Importantly, this invention makes safer growth factors available for use for cosmetic and topical treatment. These growth factors do not carry the risk of unwanted contaminants and transmissible agents that can result from animals or animal cell based expression systems, and the recombinant growth factors that plant expression systems provide are post-translationally modified proteins.

Description

field of invention [0001] In general, the present invention relates to cosmetic and pharmaceutical compositions comprising growth factors for skin care and methods of making cosmetic products. In particular, the present invention relates to recombinant non-plant growth factors, preferably human or mammalian growth factors, obtained from transgenic plants, and their use in cosmetic and pharmaceutical products. Background of the invention [0002] The skin is the largest organ in the human body and performs various functions such as protection, barrier, temperature control, excretion and respiration. It performs a variety of different functions such as protection, barrier, temperature control, excretion and respiration. With time and aging, these functions decline rapidly, and the skin undergoes various physiological changes. These changes manifest as a decrease in the thickness of the main components of the skin, the epidermis, dermis, and subcutaneous tissue. Changes in l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K8/64A61Q19/00A61Q19/08A61K38/18C12N15/82
CPCA61K38/2006A61Q19/08A61K38/1825A61K38/18A61K38/1808A61K8/64C12N15/8257A61K38/2026A61K2800/86A61K38/217A61P17/00
Inventor 比约恩·拉鲁斯·奥瓦尔埃纳尔·门蒂莱
Owner ORF ELEVATORAEKNI HF